Alto Neuroscience Ratios (2023-2026) | ANRO

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 148.28M203.64M194.48M184.57M174.73M164.90M152.44M165.85M230.47M
Equity Average (Quarter) -48.91M-56.85M-66.38M60.72M186.44M172.41M158.26M145.28M131.25M117.48M131.35M197.26M
Invested Capital (Quarter) -45.23M-52.60M-61.10M-71.67M203.06M189.83M175.21M161.71M140.35M125.41M113.56M153.14M245.37M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -22.23-27.91-26.77-33.05-41.58-52.86-54.11-51.04-26.21-28.92-23.00-29.66-49.79
Debt to Equity (Quarter) -0.140.050.060.060.070.140.160.180.110.07
Debt Ratio (Quarter) 0.110.050.050.050.060.120.130.140.090.06
Equity Ratio (Quarter) -0.830.920.910.860.850.810.780.760.820.88
Times Interest Earned (Quarter) -22.23-27.91-26.77-33.05-41.58-52.86-54.11-51.04-26.21-28.92-23.00-29.66-49.79
Valuation
Enterprise Value (Quarter) -82.50M-205.90M-193.12M-181.70M-168.20M-160.75M-147.59M-137.82M-176.48M-263.76M
Return Ratios
Return on Capital Employed (Quarter) -32.08%-27.97%-35.12%-39.30%-41.74%-44.81%-46.24%-42.95%-35.81%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.01%-0.01%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%